Mylan: Court upholds patents protecting Perforomist
PITTSBURGH — Mylan on Monday announced the U.S. District Court for the Northern District of West Virginia ruled in favor of upholding the validity of patents protecting Perforomist (formoterol fumarate) Inhalation Solution. Mylan previously sued Teva alleging that Teva’s abbreviated new drug application for this product infringed four Mylan patents covering Perforomist.
The court’s decision prevents Teva’s ANDA, which has yet to receive a tentative approval from the Food and Drug Administration.
"The court’s decision to recognize the validity of the patents covering Mylan’s Perforomist Inhalation Solution not only affirms the strength of our intellectual property on this product, but also our broader respiratory portfolio, including Mylan’s combination product currently in development," said Mylan CEO Heather Bresch. "We are excited about the growth of our respiratory franchise and look forward to continuing to meet unmet needs in this increasingly important space."
NY Times: Web-based Birchbox plans to open a Manhattan store this spring
NEW YORK — Since its launch in 2010, beauty subscription company Birchbox has shaken up the beauty market by sending subscribers boxes of product samples each month. Now, the web-based company is reportedly looking to open a physical location in Manhattan, according to a New York Times report.
According to the NY Times, founders Katia Beauchamp and Hayley Barna are quietly planning to open in the spring a store on West Broadway in the heart of SoHo’s main shopping area.
Unlike several other web-based companies that have created a brick-and-mortar-type formula that is basically a showroom for their online business, Birchbox will strive to be a complete shopping and lifestyle “experience,” the NY Times reported.
According to the article, the store will feature touch screens throughout for product recommendations and reviews, and will also house roughly 2,000 products available for purchase. Beauty mavens will also be able to build their own Birchbox for $15 in the B.Y.O.B. section. Classes and services, such as hair styling, will also be available, the NY Times reported.
APhA Foundation announces new data aggregation and reporting tool
WASHINGTON — The American Pharmacists Association Foundation and software company IQware Solutions have teamed up to create core components of an IMPACT Healthcare Innovation Hub, a new data aggregation and reporting tool that will integrate clinical and economic data.
The secure web-based platform will include data collection, importing, analytics and reporting capabilities currently used in the foundation’s research projects. Using the hub, healthcare organizations will be able to produce a set of self-service reports using uploaded data that demonstrate the value of pharmacists’ patient care services as an efficient, cost-effective healthcare solution, APhA stated.
“We are pleased to have the opportunity to develop new tools to streamline data collection and reporting in a way that produces evidence of the impact pharmacists’ patient care services have on healthcare delivery and ultimately, patient health outcomes,” said Mindy Smith, APhA Foundation executive director.
“Privacy, confidentiality, reliability and security are of paramount importance to our research at the APhA Foundation and to our collaborators,” said Benjamin Bluml, APhA Foundation SVP, research and innovation. “One of the key reasons we selected IQware as our development partner is for the flexibility its secure, patented technology offers in developing an infrastructure that allows us to adapt to a continuously evolving marketplace as we work to expand our research and innovation enterprise to help invent a preferred future.”
Healthcare organizations who use the IMPACT Healthcare Information Hub will be able to collect, analyze, report and aggregate data depending on their needs. The software will allow the option to enter data directly into the system if an electronic medical record system is not in place, convert non-standardized formats into standardized data, or accommodate market standards for health information exchange if a standard EMR system is used.